Above all, miR-296-5p attenuated EMT by inhibiting the NRG1/ERBB2/ERBB3/RAS/MAPK/Fra-2 signaling in HCC cells (Fig. 7e). The gene discussed is ERBB2; the disease is hepatocellular carcinoma.